...
首页> 外文期刊>American Journal of Case Reports >Matrix-producing metaplastic breast carcinoma – a rare malignancy
【24h】

Matrix-producing metaplastic breast carcinoma – a rare malignancy

机译:产生母体血栓乳腺癌 - 一种罕见的恶性肿瘤

获取原文
           

摘要

Background: Metaplastic breast carcinomas are ductal carcinomas that undergo metaplasia into non-glandular growth patterns. They are very rare, accounting for less than 1% of all invasive breast carcinomas.Case Report: A 33-year-old female patient presented with a lump in her left breast. Axillary lymph nodes were not palpable. FNAC of the lump was positive for malignant cells. The patient underwent modified radical mastectomy with axillary clearance. The histopathological report was matrix-producing carcinoma with infiltrating duct carcinoma. The tumor was positive for immunohistochemical markers keratin, EMA (Epithelial Membrane Antigen), and S100, thus confirming it to be matrix-producing carcinoma breast. After surgery, the patient recovered uneventfully.Conclusions: Matrix-producing breast carcinoma is a rare type of metaplastic carcinoma characterized by a ductal carcinomatous element with direct extension to areas showing cartilaginous or osseous differentiation, lacking an interspersed spindle cell component. It has better prognosis than metaplastic carcinoma.Immunohistochemically, they are positive for keratin, EMA (Epithelial Membrane Antigen), and S100. The tumor, which is matrix-producing, is S100 reactive and nonreactive for cytokeratin. They are usually ER- and PR-negative. The average age of these patients is approximately 58 years. Surgery remains the mainstay of therapy, using either mastectomy or local excision.
机译:背景:荟萃抑制乳腺癌是导管癌,其经过细胞腺癌进入非腺体生长模式。它们非常罕见,占所有侵入性乳房癌症的1%占1%的报告:一个33岁的女性患者在她的左乳房呈现出肿块。腋窝淋巴结不可触及。肿块的FNAc对恶性细胞是阳性的。患者接受了腋窝间隙的改性自由基乳房切除术。组织病理学报告是产生具有浸润管道癌的基质癌。肿瘤对于免疫组织化学标志物角蛋白,EMA(上皮膜抗原)和S100是阳性的,因此证实它是产生基质的癌乳腺癌。手术后,患者恢复了不平衡的。结论:产生基质乳腺癌是一种稀有类型的群体血管癌,其特征在于导管癌元素,其具有直接延伸到显示软骨或骨液分化的区域,缺乏散射的纺锤体细胞组分。它具有比Metaplastic癌的预后更好.Immunohistochemaly,它们是角蛋白,EMA(上皮膜抗原)和S100的阳性。产生基质的肿瘤是S100对细胞角蛋白的反应性和非反应性。它们通常是er-和pr阴性的。这些患者的平均年龄约为58年。手术仍然是治疗的主要疗法,使用乳房切除或局部切除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号